DNA polymerase alpha-primase complex (Pol α-primase complex (or Pol α/primase complex))

The DNA polymerase alpha–primase complex is a heterotetrameric enzyme found exclusively in eukaryotes that plays an essential role at the very start of chromosomal DNA replication. It consists of four subunits: two forming the primase component (PRIM1—small subunit; PRIM2—large subunit) responsible for synthesizing short RNA primers de novo, and two forming the polymerization component (POLA1—catalytic subunit; POLA2—regulatory B subunit) which extend these RNA primers with a short stretch (~20 nucleotides) of DNA before handoff to more processive replicative polymerases such as Pol δ and Pol ε[3][5][7]. This unique ability allows it to initiate both leading-strand synthesis at origins and lagging-strand Okazaki fragment formation during S phase. The structure is highly conserved from yeast through humans, with recent cryo-electron microscopy studies revealing dynamic conformational changes required for primer handoff between priming and elongation activities within the same multi-protein assembly[6][8]. The regulatory B subunit is essential for viability, coordinating early steps at origins during S phase progression[4]. Beyond its core function in primer generation, evidence suggests additional roles including participation in cellular responses to DNA damage, maintenance of telomeres, epigenetic regulation via higher-order chromatin assembly, and possibly feedback mechanisms involving iron-sulfur clusters within certain domains that sense genomic integrity[1]. Because it lacks proofreading activity—and only synthesizes short stretches—the risk from errors introduced by this enzyme is minimized by rapid replacement with high-fidelity replicative enzymes after initiation. Its fundamental importance makes it indispensable but also challenging as a direct therapeutic target due to toxicity risks associated with global inhibition.[5]

Other names

DNA polymerase alpha/primase complexPol α/primasePrimosome (in the context of eukaryotic replication)DNA pol alpha-DNA primase complex

Drugs that would target this molecule would likely act by inhibiting its priming activity or blocking primer extension, thereby halting initiation of chromosomal replication and cell division.